Such protocol requires at least 10 days of treatment to obtain pituitary desensitization and FSH stimulation may induce a higher ovarian response and a higher risk of ovarian hyperstimulation syndrome (OHSS) than with GnRH antagonist protocols [1]. Here, BRD2 is linked to ovarian hyperstimulation syndrome.